← All stocks

TIMBERLAND BANCORP INC

TSBK Mostly scheduled
CIK 0001046050 #3372 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$93.13K
$0.00 on a plan · $91.74K straight out of an exercise
Sold at will
$1.39K
1 of 2 sales
Net
−$93.13K
−$1.39K against sales at will

By person

14 insiders · 2 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
DRUGGE ROBERT A
Director
$91.74K (1) scheduled
−$91.74K
38,245
0.4919%
$1.75M
+19.5%
Antich Breanne D
Chief Technology Officer/EVP
$1.39K (1)
−$1.39K
3,890
0.0500%
$178.43K
+289.0%
BRYDON DEAN J
CEO
71,031
0.9135%
$3.26M
+9.0%
SMITH DAVID ALAN
Director
18,468
0.2375%
$847.13K
+7.9%
CLINTON ANDREA M
Director
17,820
0.2292%
$817.40K
+8.2%
DeBord Matthew J
Chief Lending Officer, EVP
11,400
0.1466%
$522.92K
+46.2%
STONEY MICHAEL JOHN
Director
9,040
0.1163%
$414.66K
+15.2%
Fischer Jonathan Arthur
President/COO
6,550
0.0842%
$300.45K
+138.2%
BASICH MARCI A
Chief Financial Officer/EVP
4,800
0.0617%
$220.18K
+220.0%
Seath Matthew Douglas
Chief Risk Officer/EVP
3,155
0.0406%
$144.72K
0.0%
Van Cise Todd
Chief Credit Officer/EVP
2,500
0.0322%
$114.68K
+108.3%
Suter Kelly
Director
2,445
0.0314%
$112.15K
+122.3%
Bhandari Parul
Director
1,945
0.0250%
$89.22K
+224.2%
Leodler Kathy D
Director
1,735
0.0223%
$79.58K
+115.5%
Insider
Date
Role
Action
Shares
Price
Amount
DRUGGE ROBERT A
18 Aug 2026
Director
Sold after exercise
2,000
$45.87
$91.74K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,000
History held since 29 Sep 2016